Ke, W., Zhang, L., & Dai, Y. (2020). The role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs). Thorac Cancer.
استشهاد بنمط شيكاغوKe, Wanhai, Li Zhang, و Yan Dai. "The Role of IL‐6 in Immunotherapy of Non‐small Cell Lung Cancer (NSCLC) With Immune‐related Adverse Events (irAEs)." Thorac Cancer 2020.
MLA استشهادKe, Wanhai, Li Zhang, و Yan Dai. "The Role of IL‐6 in Immunotherapy of Non‐small Cell Lung Cancer (NSCLC) With Immune‐related Adverse Events (irAEs)." Thorac Cancer 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.